Clinical Trial: CARv3-TEAM-E T Cells in Glioblastoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Glioblastoma
Study Type: INTERVENTIONAL
Official Title: INCIPIENT: INtraventricular CARv3-TEAM-E T Cells for PatIENTs With GBM
Brief Summary:
The goal of this research study is to determine the best dose of CARv3-TEAM-E T Cells for treating participants with glioblastoma.The name of the treatment intervention used in this research study is:-CARv3-TEAM-E T Cells (or Autologous T lymphocytes).
Read more